Compare Fifth Third Bancorp Common Stock (FITB) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fifth Third Bancorp Common Stock vs Immunovant Inc. Common Stock — how do they compare? Fifth Third Bancorp Common Stock trades at $50.15 (market cap $45.98B), while Immunovant Inc. Common Stock trades at $30.27 (market cap $6.25B). The key difference: Fifth Third Bancorp Common Stock is far larger — about 7.4× Immunovant Inc. Common Stock's market cap, and Fifth Third Bancorp Common Stock pays a 3.31% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fifth Third Bancorp Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FITB | IMVT | |
|---|---|---|
Market Cap | $45.98B | $6.25B |
Volume | 10,522,320 | 1,755,411 |
Sector | Financials | Health |
52-Week High | $59.37 | $44.96 |
52-Week Low | $40.36 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $63.85B | $5.35B |
Dividend Yield | 3.31% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fifth Third Bancorp Common Stock
Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
